Published • loading... • Updated
Johnson & Johnson Reports Q3 2026 Results, Raises 2026 Guidance
The company cited 7.7% pharmaceutical growth and raised full-year guidance after adjusted earnings topped Wall Street estimates.
- Johnson & Johnson shares slipped in premarket trading on Tuesday despite reporting third-quarter revenue of $25.4 billion and raising full-year sales guidance to between $101.0 billion and $101.4 billion.
- Innovative Medicine, the company's pharmaceutical business, posted sales of $16.76 billion with 7.7% growth, while the MedTech division grew only 2.5% to $8.64 billion, highlighting uneven segment performance.
- Chief Financial Officer Joe Wolk cited geopolitical tensions and European budget cuts as international headwinds, telling Bloomberg, "Medtech needs to improve quite frankly."
- J&J intends to separate its orthopedics unit, with Wolk confirming the company is "leaning towards a straight spin" rather than a sale to create shareholder value.
- The company raised fiscal 2026 adjusted earnings guidance to $11.10 per share and declared a fourth-quarter cash dividend of $1.34 per share, payable on December 8.
Insights by Ground AI
14 Articles
14 Articles
Johnson & Johnson Q3 Profit Plunges, Lifts FY26 Outlook; Stock Drops
Drug major Johnson & Johnson on Tuesday reported sharply lower third-quarter profit on special charges, despite sales growth. Further, the firm raised its fiscal 2026 outlook again and announced a quarterly dividend. In pre-market activity, the shares were losing around 2.6 percent.
J&J beats earnings estimates; Middle East war hits sales
Johnson & Johnson has reported a slightly higher-than-expected profit, driven by strong sales of immune disease treatment Tremfya, but geopolitical issues including the Middle East conflict were a drag on its medical devices business.
·Ireland
Read Full Article
Hastings TribuneReposted by 
Business Wire
Business WireJohnson & Johnson reports Q3 2026 results, raises 2026 guidance
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct 13, 2026-
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources14
Leaning Left1Leaning Right1Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 17%
C 67%
R 16%
Factuality
To view factuality data please Upgrade to Premium
